Literature DB >> 8904192

Treatment of factor VII deficiency with recombinant factor VIIa.

K A Bauer1.   

Abstract

Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIIa has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VII-deficient patients with a therapeutic agent that is not derived from human plasma.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8904192     DOI： 10.1159/000217259

Source DB:  PubMed          Journal:  Haemostasis        ISSN： 0301-0147


  4 in total

1.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

2.  Pediatric cardiac intervention in a case of congenital factor VII deficiency: a challenge to overcome.

Authors:  Dibyendu De; Hemant Kumar Nayak; Suvro Sankha Datta; Nurul Islam; Sandeepan Halder
Journal:  Indian J Hematol Blood Transfus       Date:  2017-06-06       Impact factor: 0.900

Review 3.  Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in a Pregnant Woman with Severe Hypoproconvertinemia-A Case Series and Review of the Literature.

Authors:  Arkadiusz Krzyżanowski; Tomasz Gęca; Bożena Sokołowska; Maciej Kwiatek; Andrzej Miturski; Aleksandra Stupak; Piotr Terlecki; Piotr Paluszkiewicz; Anna Kwaśniewska
Journal:  Int J Environ Res Public Health       Date:  2022-09-01       Impact factor: 4.614

4.  Screening platelet function in blood donors.

Authors:  Pascal Pedini; Jean-Baptiste Baudey; Katia Pouymayou; Celine Falaise; Manal Ibrahim-Kosta; Melanie Vélier; Clémence Demerle; Hajer Graiet; Catherine Dragutini; Anne-Marie Dombey; Jacques Chiaroni; Marie Christine Alessi; Christophe Picard
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.